Lobo Kevin insider trades
Lobo Kevin has filed 29 Form 4s with the SEC that we hold, for Stryker Corp (SYK) (Chair and CEO, Director), Parker-Hannifin Corp (PH) (Director) and GE HealthCare Technologies Inc. (GEHC) (Director). Across all of them we count 1 purchase worth $641.8K and 9 sales worth $53.5M reported on Form 4. In the last 12 months: 1 purchase ($641.8K) and 0 sales ($0). The largest single trade was a sale of 43,809 shares of Stryker Corp worth $10.5M, dated 2022-12-02. The first filing on our record is dated 2021-10-29 and the latest 2026-05-26.
Stryker Corp (SYK)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2022-12-02 | S, sale reported on Form 4 | 43,809 | $10.5M | 2022-12-05 |
| 2022-12-02 | S, sale reported on Form 4 | 23,423 | $5.6M | 2022-12-05 |
| 2023-11-17 | S, sale reported on Form 4 | 8,060 | $2.3M | 2023-11-21 |
| 2023-11-17 | S, sale reported on Form 4 | 474 | $137.4K | 2023-11-21 |
| 2023-11-17 | S, sale reported on Form 4 | 32,857 | $9.4M | 2023-11-21 |
| 2023-11-17 | S, sale reported on Form 4 | 15,092 | $4.4M | 2023-11-21 |
| 2024-11-07 | S, sale reported on Form 4 | 15,866 | $5.9M | 2024-11-08 |
| 2024-11-07 | S, sale reported on Form 4 | 18,269 | $6.7M | 2024-11-08 |
| 2024-11-07 | S, sale reported on Form 4 | 23,178 | $8.5M | 2024-11-08 |
Parker-Hannifin Corp (PH)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
GE HealthCare Technologies Inc. (GEHC)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2026-05-22 | P, purchase reported on Form 4 | 10,000 | $641.8K | 2026-05-26 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1519419) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms